- Home
- SES vs HUMA Comparison
SES vs HUMA Comparison
Compare SES & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SES
- HUMA
- Stock Information
- Founded
- SES 2012
- HUMA 2004
- Country
- SES United States
- HUMA United States
- Employees
- SES N/A
- HUMA N/A
- Industry
- SES Auto Parts:O.E.M.
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- SES Consumer Discretionary
- HUMA Health Care
- Exchange
- SES Nasdaq
- HUMA Nasdaq
- Market Cap
- SES 340.3M
- HUMA 356.8M
- IPO Year
- SES N/A
- HUMA N/A
- Fundamental
- Price
- SES $1.20
- HUMA $2.53
- Analyst Decision
- SES Hold
- HUMA Strong Buy
- Analyst Count
- SES 3
- HUMA 7
- Target Price
- SES $1.50
- HUMA $13.00
- AVG Volume (30 Days)
- SES 8.5M
- HUMA 4.1M
- Earning Date
- SES 08-04-2025
- HUMA 08-12-2025
- Dividend Yield
- SES N/A
- HUMA N/A
- EPS Growth
- SES N/A
- HUMA N/A
- EPS
- SES N/A
- HUMA N/A
- Revenue
- SES $7,833,000.00
- HUMA $517,000.00
- Revenue This Year
- SES $916.42
- HUMA N/A
- Revenue Next Year
- SES $151.67
- HUMA $858.42
- P/E Ratio
- SES N/A
- HUMA N/A
- Revenue Growth
- SES N/A
- HUMA N/A
- 52 Week Low
- SES $0.20
- HUMA $1.15
- 52 Week High
- SES $2.53
- HUMA $9.79
- Technical
- Relative Strength Index (RSI)
- SES 66.13
- HUMA 54.67
- Support Level
- SES $1.08
- HUMA $2.28
- Resistance Level
- SES $1.28
- HUMA $2.84
- Average True Range (ATR)
- SES 0.09
- HUMA 0.23
- MACD
- SES 0.03
- HUMA 0.02
- Stochastic Oscillator
- SES 76.67
- HUMA 47.46
About SES SES AI Corporation
SES AI Corp is a developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (Li-Metal) and Lithium-ion (Li-ion) rechargeable battery technologies for electric vehicles (EVs), Urban Air Mobility (UAM), drones, robotics, Battery Energy Storage Systems (BESS) and other applications. It includes Software and Hardware products that are EV, UAM, Drone, Molecular Universe, and Avatar.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.